The French radio France Inter dedicates a report to BOYDSense

In the program named “Le Zoom de la rédaction” of Tuesday, May 23rd, the journalist Sophie Bécherel gives the floor to Pierre Sbabo, CEO of Alpha MOS, and Bruno Thuillier, founder of BOYDSense.

In this report entitled “Blowing instead of pricking yourself”, the company based in Toulouse explains how its future developments could enable diabetes patients to monitor their blood sugar levels via a quick and painless analysis of exhaled air.

Listen to the report on France Inter (In French):…


About BOYDSense

BOYDSense, Inc. is a medical technology company developing affordable, non-invasive tools for measuring critical biomarkers via exhaled breath. Its mission is to build the platform for anywhere, anytime biosignature capture and display to help consumers better manage their conditions. Breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using them to diagnose and monitor chronic diseases, such as diabetes. The BOYDSense platform will also allow consumers and healthcare providers to use breath as a non-invasive medium to detect and monitor diseases like cancer, obesity, asthma, and others. BOYDSense’s first product under development, the g-Sense Breath Meter, is an affordable handheld device that allows people with diabetes to accurately measure blood glucose values through breath-based VOCs without the cost, pain, and social stigma associated with conventional fingerstick glucose testing. BOYDSense is an Alpha MOS company, the leader in volatile organic compound analysis.

For more information, please visit: